DK2991507T3 - Anvendelse af en sammensætning omfattende fiskeolie og juice til behandling og/eller efterbehandling af cancer - Google Patents

Anvendelse af en sammensætning omfattende fiskeolie og juice til behandling og/eller efterbehandling af cancer Download PDF

Info

Publication number
DK2991507T3
DK2991507T3 DK14726214T DK14726214T DK2991507T3 DK 2991507 T3 DK2991507 T3 DK 2991507T3 DK 14726214 T DK14726214 T DK 14726214T DK 14726214 T DK14726214 T DK 14726214T DK 2991507 T3 DK2991507 T3 DK 2991507T3
Authority
DK
Denmark
Prior art keywords
treatment
juice
cancer
post
composition
Prior art date
Application number
DK14726214T
Other languages
English (en)
Inventor
Janne Sande Mathisen
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50792503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2991507(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smartfish As filed Critical Smartfish As
Application granted granted Critical
Publication of DK2991507T3 publication Critical patent/DK2991507T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK14726214T 2013-04-22 2014-04-22 Anvendelse af en sammensætning omfattende fiskeolie og juice til behandling og/eller efterbehandling af cancer DK2991507T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20130552 2013-04-22
PCT/NO2014/050061 WO2014175748A1 (en) 2013-04-22 2014-04-22 Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer

Publications (1)

Publication Number Publication Date
DK2991507T3 true DK2991507T3 (da) 2019-11-04

Family

ID=50792503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14726214T DK2991507T3 (da) 2013-04-22 2014-04-22 Anvendelse af en sammensætning omfattende fiskeolie og juice til behandling og/eller efterbehandling af cancer

Country Status (18)

Country Link
US (2) US9877944B2 (da)
EP (1) EP2991507B2 (da)
JP (1) JP6495245B2 (da)
KR (1) KR102253929B1 (da)
CN (1) CN105120683A (da)
AU (1) AU2014258007B2 (da)
BR (1) BR112015025787B1 (da)
CA (1) CA2909409A1 (da)
DK (1) DK2991507T3 (da)
ES (1) ES2753387T3 (da)
HR (1) HRP20191912T1 (da)
HU (1) HUE046885T2 (da)
LT (1) LT2991507T (da)
MX (1) MX370055B (da)
PL (1) PL2991507T3 (da)
PT (1) PT2991507T (da)
SI (1) SI2991507T1 (da)
WO (1) WO2014175748A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX370055B (es) 2013-04-22 2019-11-29 Smartfish As Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.
EP3283061A4 (en) * 2015-04-14 2019-04-17 Atossa Genetics Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST DISEASES AND ORGANISM-RELATED ILLNESSES
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
US11206861B2 (en) 2016-10-03 2021-12-28 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
CA3066742A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
WO2018231943A2 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
KR102775757B1 (ko) 2017-06-13 2025-02-28 호운 사이먼 샤 암 방사선요법을 향상시키기 위한 조성물 및 방법
CN108208838A (zh) * 2018-03-09 2018-06-29 北京素维生物科技有限公司 一种掩味组合物及其用途
WO2020225217A1 (en) * 2019-05-07 2020-11-12 Lynxit Sport Nutrition As Omega-3 beverage
CN113413532B (zh) * 2021-07-01 2022-03-01 曾迎春 基于虚拟现实的癌症相关认知障碍评估与康复训练系统
CN115317543B (zh) * 2022-09-13 2023-05-23 复旦大学附属金山医院(上海市金山区眼病防治所、上海市金山区核化伤害应急救治中心) 一种治疗肝癌恶病质的中药组合物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175468A3 (en) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
GB9423625D0 (en) 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
CA2260397A1 (en) * 1999-01-29 2000-07-29 Atlantis Marine Inc. Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
JP2000281572A (ja) * 1999-03-30 2000-10-10 Bizen Kasei Kk 殺癌細胞剤及びこれを配合してなる組成物
US20020012710A1 (en) 1999-11-29 2002-01-31 Rimonest Ltd. Pomegranate products useful in improving health and methods of use thereof
US20020188024A1 (en) 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
NO317310B1 (no) * 2003-02-28 2004-10-04 Bioli Innovation As Olje-i-vann emulsjonskonsentrat for ernaeringsformal, samt anvendelse derav.
GB0503684D0 (en) * 2005-02-23 2005-03-30 Ici Plc Emulsifiers and emulsions
ES2264886B1 (es) 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
CN100418427C (zh) * 2005-09-13 2008-09-17 仙桃市泰尔生物科技开发有限公司 保健型鱼奶加工方法
NO324262B1 (no) * 2005-11-29 2007-09-17 Pharmalogica As Bruksklar sammensetning omfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder.
NO20081487L (no) * 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
CN102438468B (zh) * 2009-04-17 2014-06-04 纳塔克制药有限公司 富含低含量植烷酸的ω-3脂肪酸的组合物
MX370055B (es) 2013-04-22 2019-11-29 Smartfish As Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.

Also Published As

Publication number Publication date
EP2991507B1 (en) 2019-08-07
BR112015025787A2 (pt) 2017-07-25
KR102253929B1 (ko) 2021-05-20
CA2909409A1 (en) 2014-10-30
AU2014258007A1 (en) 2015-10-15
MX370055B (es) 2019-11-29
BR112015025787A8 (pt) 2019-12-24
BR112015025787B1 (pt) 2021-01-12
PT2991507T (pt) 2019-11-12
AU2014258007B2 (en) 2019-01-17
HK1221874A1 (en) 2017-06-16
JP6495245B2 (ja) 2019-04-03
US10188622B2 (en) 2019-01-29
JP2016517865A (ja) 2016-06-20
US20160067202A1 (en) 2016-03-10
EP2991507B2 (en) 2026-01-07
MX2015014713A (es) 2016-06-06
US20180110749A1 (en) 2018-04-26
US9877944B2 (en) 2018-01-30
KR20160008200A (ko) 2016-01-21
WO2014175748A1 (en) 2014-10-30
CN105120683A (zh) 2015-12-02
ES2753387T3 (es) 2020-04-08
HUE046885T2 (hu) 2020-03-30
PL2991507T3 (pl) 2020-02-28
LT2991507T (lt) 2019-12-10
EP2991507A1 (en) 2016-03-09
HRP20191912T1 (hr) 2020-01-10
SI2991507T1 (sl) 2020-02-28

Similar Documents

Publication Publication Date Title
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
IL254294A0 (en) Topical regional neuro-affective therapy with cannabinoids
IL257105A (en) Modified cells and methods of therapy
PL3157511T3 (pl) Zastosowanie kannabinoidów w leczeniu padaczki
EP3344400A4 (en) Three dimensional microtissue bioprinter
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3035926T3 (da) Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
PL3198009T3 (pl) Onkolityczne wirusy nowotworowe i sposoby zastosowania
DK3076976T3 (da) Fremgangsmåder til behandling af cancer
DK2994157T3 (da) Tafa4-forbindelser og anvendelser deraf til behandling af smerte
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
IL247354A0 (en) Treatment of conditions associated with hyperinsulinaemia
HRP20182134T1 (hr) Triazinski spoj i njegova upotreba u medicinske svrhe
HUE046885T2 (hu) Halolajat és dzsúzt tartalmazó készítmény alkalmazása rák kezelésére és/vagy utókezelésére
DK3083683T3 (da) Sammensætninger og fremgangsmåder til behandling af fedtvævsansamlinger
DK2958926T3 (da) Epidithiodioxopiperazinforbindelse eller derivater deraf og anvendelse deraf
DK3374497T3 (da) Modificerede makrofager til anvendelse i behandlingen af kræft
DK3236960T3 (da) Fluralaner til anvendelse i behandling af demodicose
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
IL258856A (en) Solabegron zwitterion and uses thereof
IL256111B1 (en) Pac–1 combination therapy